Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Drug Study of Albuterol to Treat Acute Lung Injury

ClinicalTrials.gov ID: NCT00434993

Public ClinicalTrials.gov record NCT00434993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo in Acute Lung Injury

Study identification

NCT ID
NCT00434993
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
282 participants

Conditions and interventions

Interventions

  • Albuterol Sulfate Drug
  • Mini-Bronchoalveolar Lavage (BAL) Procedure
  • Placebo Drug

Drug · Procedure

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Aug 31, 2008
Completion
Oct 31, 2008
Last update posted
Feb 9, 2017

2007 – 2008

United States locations

U.S. sites
40
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
University of San Francisco-Fresno Medical Center Fresno California
University of California, Davis Medical Center Sacramento California
UCSF-Moffitt Hospital San Francisco California
UCSF-San Francisco General Hospital San Francisco California
Centura St. Anthony Central Hospital Denver Colorado
Denver Health Medical Center Denver Colorado
Rose Medical Center Denver Colorado
University of Colorado Health Sciences Center Denver Colorado
Washington Hospital Center Washington D.C. District of Columbia
Baton Rouge General Hospital-Blue Bonnet Baton Rouge Louisiana
Baton Rouge General Hospital-Midcity Baton Rouge Louisiana
Earl K. Long Medical Center Baton Rouge Louisiana
Our Lady of the Lake Regional Medical Center Baton Rouge Louisiana
Medical Center of Louisiana New Orleans Louisiana
Ochsner Clinic Foundation New Orleans Louisiana
Tulane University Health Sciences Center New Orleans Louisiana
Baltimore VA Medical Center Baltimore Maryland
Johns Hopkins Bayview Medical Center Baltimore Maryland
Johns Hopkins Hospital Baltimore Maryland
University of Maryland Shock Trauma Center Baltimore Maryland
Baystate Medical Center Springfield Massachusetts
Rochester Methodist Hospital Rochester Minnesota
St. Mary's Hospital, Mayo Clinic Rochester Minnesota
University of North Carolina Chapel Hill North Carolina
Duke University Medical Center Durham North Carolina
Durham Regional Medical Center Durham North Carolina
Moses Cone Health System Greensboro North Carolina
Wesley Long Community Hospital Greensboro North Carolina
Wake Forest University Baptist Medical Center Winston-Salem North Carolina
Cleveland Clinic Foundation Cleveland Ohio
MetroHealth Medical Center Cleveland Ohio
University Hospitals of Cleveland Cleveland Ohio
Vanderbilt University Medical Center Nashville Tennessee
Baylor College of Medicine Houston Texas
McKay-Dee Hospital Ogden Utah
Utah Valley Regional Medical Center Provo Utah
LDS Hospital Salt Lake City Utah
University of Virginia Medical Center Charlottesville Virginia
Harborview Medical Center Seattle Washington
University of Washington Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00434993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2017 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00434993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →